Testing effectiveness (Phase 2)Study completedNCT02053376
What this trial is testing
Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Who this might be right for
Metastatic Biliary Tract Carcinoma
Nathan Bahary, MD 43